N-[(6-amino-2-pyridinyl)sulfonyl]-6-(1-methylindol-4-yl)-2-(2,4,6-trimethylphenoxy)pyridine-3-carboxamide
C29H27N5O4S — CID 121250568
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(6-amino-2-pyridinyl)sulfonyl]-6-(1-methylindol-4-yl)-2-(2,4,6-trimethylphenoxy)pyridine-3-carboxamide
N-[(6-amino-2-pyridinyl)sulfonyl]-6-(1-methylindol-4-yl)-2-(2,4,6-trimethylphenoxy)pyridine-3-carboxamide (PubChem CID 121250568) has the molecular formula C29H27N5O4S and a molecular weight of 541.63 g/mol. Its IUPAC name is N-[(6-amino-2-pyridinyl)sulfonyl]-6-(1-methylindol-4-yl)-2-(2,4,6-trimethylphenoxy)pyridine-3-carboxamide.
Molecular Properties
| Compound Name | N-[(6-amino-2-pyridinyl)sulfonyl]-6-(1-methylindol-4-yl)-2-(2,4,6-trimethylphenoxy)pyridine-3-carboxamide |
|---|---|
| PubChem CID | 121250568 |
| Molecular Formula | C29H27N5O4S |
| Molecular Weight | 541.63 g/mol |
| Exact Mass | 541.18 |
| IUPAC Name | N-[(6-amino-2-pyridinyl)sulfonyl]-6-(1-methylindol-4-yl)-2-(2,4,6-trimethylphenoxy)pyridine-3-carboxamide |
| SMILES | Cc1cc(C)c(Oc2nc(-c3cccc4c3ccn4C)ccc2C(=O)NS(=O)(=O)c2cccc(N)n2)c(C)c1 |
| InChI | InChI=1S/C29H27N5O4S/c1-17-15-18(2)27(19(3)16-17)38-29-22(28(35)33-39(36,37)26-10-6-9-25(30)32-26)11-12-23(31-29)20-7-5-8-24-21(20)13-14-34(24)4/h5-16H,1-4H3,(H2,30,32)(H,33,35) |
| InChIKey | ZPSAHSFJYPFJSD-UHFFFAOYSA-N |
| XLogP | 5.05 |
| TPSA | 129.20 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 541.63 |
| LogP ≤ 5 | 5.05 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121250568 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.